Skip to main content
Article thumbnail
Location of Repository

The use of knowledge translation and legal proceedings to support evidence-based drug policy in Canada: opportunities and ongoing challenges

By Kora DeBeck and Thomas Kerr
Topics: Analysis and Comment
Publisher: Open Medicine Publications, Inc.
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (1998). and injection drug use in British Columbia: pay now or pay later? Victoria: BC Provincial Health Officer, BC Ministry of Health.
  2. Closing the gap between evidence and action: the need for knowledge translation in the field of drug policy research.
  3. Developing good taste in evidence”: facilitators of and hindrances to evidence-informed health policymaking in state government.
  4. Health policy-makers’ perceptions of their use of evidence: a systematic review.
  5. How do drug policy makers access research evidence?
  6. How to translate health research knowledge into effective healthcare action.
  7. (2006). Inc. Record disclosed under the Canadian Access to Information Act: PCO Corporate Communication.
  8. Making evidence-based medicine doable in everyday practice.
  9. Methodology for evaluating Insite: Canada’s first medically supervised safer injection facility for injection drug users.
  10. Needle exchange is not enough: lessons from the Vancouver injecting drug use study.
  11. Rationale for evaluating North America’s first medically supervised safer-injecting facility.
  12. Research dissemination: actively bringing the research and policy worlds together.
  13. Science and the war on drugs: a hard habit to break.
  14. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility.
  15. Task Force. Evaluating the teaching of evidence based medicine: conceptual framework.
  16. The Canadian government’s treatment of scientific process and evidence: inside the evaluation of North America’s first supervised injecting facility.
  17. The implicit rules of evidence-based drug policy: a U.S. perspective.
  18. Time to act: a call for com-prehensive responses to HIV in people who use drugs.
  19. Why does research have so little impact on American drug policy?

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.